PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-80.96%
Both yoy net incomes decline, with AVGO at -59.09%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
12.69%
D&A growth well above AVGO's 5.00%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
70.51%
Deferred tax of 70.51% while AVGO is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
No Data
No Data available this quarter, please select a different quarter.
171.65%
Less working capital growth vs. AVGO's 1150.00%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
No Data
No Data available this quarter, please select a different quarter.
163.16%
Inventory growth well above AVGO's 125.93%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
No Data
No Data available this quarter, please select a different quarter.
175.28%
Some yoy usage while AVGO is negative at -205.88%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-5.56%
Negative yoy while AVGO is 139.13%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
6.27%
Operating cash flow growth below 50% of AVGO's 90.00%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
60.91%
CapEx growth well above AVGO's 5.26%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-46066.67%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
133.33%
Liquidation growth of 133.33% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
-969.75%
Both yoy lines negative, with AVGO at -850.00%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-50.00%
Negative yoy issuance while AVGO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
10.02%
Buyback growth of 10.02% while AVGO is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.